RotaTeq: Side Effects & Dosing

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Side Effects Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Live, oral pentavalent vaccine, rotavirus

Indications/Uses

Prevention of rotavirus gastroenteritis in infants & childn caused by serotypes G1, G2, G3, G4 & G-serotypes containing P1A[8] (eg, G9).

Click to view RotaTeq detailed prescribing information

Dosage/Direction for Use

Vaccination series: 3 doses administered orally to infant. 1st dose: At 6-12 wk; subsequent doses should be administered at min: 4-wk interval between each dose.

Click to view RotaTeq detailed prescribing information

Overdosage

View RotaTeq overdosage for action to be taken in the event of an overdose.

Administration

May be taken with or without food: Gently squeeze liqd into infant's mouth toward the inner cheek until dosing tube is empty.

Contraindications

Hypersensitivity to vaccine or after previous dose. Severe combined immunodeficiency disease (SCID).

Click to view RotaTeq detailed prescribing information

Special Precautions

Not to be inj. Individuals w/ malignancies or immunocompromised or those receiving immunosuppressive therapy; HIV-infected; those who have received blood transfusion or products eg, Ig w/in 42 days. Acute infection or febrile illness. Infants w/ active GI illness, chronic diarrhea, growth retardation or history of congenital abdominal disorders or intussusception. Infants <6 wk.

Click to view RotaTeq detailed prescribing information

Use In Pregnancy & Lactation

Click to view RotaTeq detailed prescribing information

Adverse Reactions

Diarrhea, vomiting; pyrexia.

Storage

View RotaTeq storage conditions for details to ensure optimal shelf-life.

Description

View RotaTeq description for details of the chemical structure and excipients (inactive components).

Action

View RotaTeq mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Vaccines, Antisera & Immunologicals

ATC Classification

J07BH01 - rota virus, live attenuated ; Belongs to the class of rota virus diarrhea viral vaccines.

Regulatory Classification

Presentation/Packing

Form

RotaTeq vaccine (oral) (pre-filled unit-dose) 2 mL

Packing/Price

(pre-filled unit-dose) 10 × 1's; (pre-filled unit-dose) 1's

RotaTeq

rotavirus vaccine

Manufacturer:

Merck Sharp & Dohme

Distributor:

Zuellig Pharma